Location History:
- Aorora, CO (US) (2020)
- Arora, CO (US) (2017 - 2024)
Company Filing History:
3 out of 46 
2 out of 80 
Years Active: 2017-2024
Title: The Innovations of Jeff Griebel
Introduction
Jeff Griebel is a notable inventor based in Aurora, Colorado, with a significant contribution to the field of medical technology. He holds five patents, showcasing his dedication to advancing healthcare solutions. His work primarily focuses on the administration and monitoring of nitric oxide in ex vivo fluids, which has important implications for organ transplantation and patient care.
Latest Patents
One of Jeff Griebel's latest patents involves systems and methods for monitoring the administration of nitric oxide (NO) to ex vivo fluids. This innovation is particularly relevant for fluids such as blood in extracorporeal membrane oxygenation (ECMO) circuits or perfusion fluids used for preserving ex vivo organs prior to transplantation. The described systems allow for the administration of nitric oxide to the fluid, monitoring of nitric oxide or a nitric oxide marker, and adjustments to the nitric oxide administration as needed.
Career Highlights
Throughout his career, Jeff has worked with prominent companies in the pharmaceutical industry, including Mallinckrodt Pharmaceuticals and Mallinckrodt Hospital Products. His experience in these organizations has contributed to his expertise in medical innovations and patent development.
Collaborations
Jeff has collaborated with notable professionals in his field, including Jim Potenziano and Douglas R. Hansell. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Jeff Griebel's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving healthcare solutions. His work in monitoring nitric oxide administration is a testament to the importance of innovation in medicine.